tempus ai - TEM
TEM
Close Chg Chg %
53.50 -0.60 -1.12%
Closed Market
52.90
-0.60 (1.12%)
Volume: 9.01M
Last Updated:
Apr 25, 2025, 4:00 PM EDT
Company Overview: tempus ai - TEM
TEM Key Data
| Open $53.15 | Day Range 52.22 - 54.55 |
| 52 Week Range N/A - N/A | Market Cap $9.26B |
| Shares Outstanding 173.03M | Public Float 78.44M |
| Beta 7.76 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$4.75 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 9.86M |
TEM Performance
| 1 Week | 32.26% | ||
| 1 Month | 11.85% | ||
| 3 Months | 4.09% | ||
| 1 Year | N/A | ||
| 5 Years | N/A |
TEM Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
14
Full Ratings ➔
About tempus ai - TEM
Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.
TEM At a Glance
Tempus AI, Inc.
600 West Chicago Avenue
Chicago, Illinois 60654
| Phone | N/A | Revenue | 693.40M | |
| Industry | Packaged Software | Net Income | -705,809,000.00 | |
| Sector | Technology Services | 2024 Sales Growth | 30.382% | |
| Fiscal Year-end | 12 / 2025 | Employees | 2,400 | |
| View SEC Filings |
TEM Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 7.893 |
| Price to Book Ratio | 97.148 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -8.436 |
| Enterprise Value to Sales | 7.922 |
| Total Debt to Enterprise Value | 0.085 |
TEM Efficiency
| Revenue/Employee | 288,915.833 |
| Income Per Employee | -294,087.083 |
| Receivables Turnover | 4.479 |
| Total Asset Turnover | 0.931 |
TEM Liquidity
| Current Ratio | 2.294 |
| Quick Ratio | 2.162 |
| Cash Ratio | 1.54 |
TEM Profitability
| Gross Margin | 53.201 |
| Operating Margin | -99.277 |
| Pretax Margin | -101.142 |
| Net Margin | -101.79 |
| Return on Assets | -94.729 |
| Return on Equity | N/A |
| Return on Total Capital | -134.585 |
| Return on Invested Capital | -195.229 |
TEM Capital Structure
| Total Debt to Total Equity | 830.853 |
| Total Debt to Total Capital | 89.257 |
| Total Debt to Total Assets | 50.544 |
| Long-Term Debt to Equity | 819.388 |
| Long-Term Debt to Total Capital | 88.026 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Tempus Ai - TEM
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 257.85M | 320.67M | 531.82M | 693.40M | |
Sales Growth
| +37.15% | +24.36% | +65.85% | +30.38% | |
Cost of Goods Sold (COGS) incl D&A
| 180.46M | 198.99M | 253.97M | 324.50M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 23.88M | 30.41M | 33.33M | 37.24M | |
Depreciation
| 13.76M | 17.07M | 21.56M | 26.36M | |
Amortization of Intangibles
| 10.12M | 13.34M | 11.77M | 10.89M | |
COGS Growth
| +9.26% | +10.26% | +27.63% | +27.77% | |
Gross Income
| 77.39M | 121.68M | 277.86M | 368.89M | |
Gross Income Growth
| +238.99% | +57.23% | +128.35% | +32.76% | |
Gross Profit Margin
| +30.01% | +37.95% | +52.25% | +53.20% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 321.37M | 390.82M | 474.34M | 1.06B | |
Research & Development
| 128.35M | 160.88M | 185.50M | 316.84M | |
Other SG&A
| 193.02M | 229.94M | 288.84M | 740.43M | |
SGA Growth
| +48.26% | +21.61% | +21.37% | +122.89% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | 999.00K | (8.40M) | (103.13M) | |
EBIT after Unusual Expense
| (243.98M) | (270.14M) | (188.08M) | (585.25M) | |
Non Operating Income/Expense
| 575.00K | 2.89M | 21.42M | (62.41M) | |
Non-Operating Interest Income
| 623.00K | 3.03M | 7.60M | 11.08M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 15.18M | 21.89M | 46.87M | 53.65M | |
Interest Expense Growth
| +51.24% | +44.19% | +114.07% | +14.47% | |
Gross Interest Expense
| 15.18M | 21.89M | 46.87M | 53.65M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (258.59M) | (289.15M) | (213.53M) | (701.32M) | |
Pretax Income Growth
| -22.35% | -11.82% | +26.15% | -228.44% | |
Pretax Margin
| -100.29% | -90.17% | -40.15% | -101.14% | |
Income Tax
| - | 66.00K | 288.00K | 266.00K | |
Income Tax - Current - Domestic
| - | 66.00K | 52.89M | 205.74M | |
Income Tax - Current - Foreign
| - | - | 152.00K | 188.00K | - |
Income Tax - Deferred - Domestic
| - | - | (52.76M) | (205.52M) | - |
Income Tax - Deferred - Foreign
| - | - | - | (146.00K) | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (259.19M) | (289.81M) | (214.12M) | (705.81M) | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (259.19M) | (289.81M) | (214.12M) | (705.81M) | |
Net Income Growth
| -23.51% | -11.81% | +26.12% | -229.64% | |
Net Margin Growth
| -100.52% | -90.38% | -40.26% | -101.79% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (259.19M) | (289.81M) | (214.12M) | (705.81M) | |
Preferred Dividends
| 38.54M | 44.12M | 51.85M | 40.52M | |
Net Income Available to Common
| (297.74M) | (333.93M) | (265.96M) | (746.33M) | |
EPS (Basic)
| -1.7527 | -1.9657 | -1.7251 | -4.6035 | |
EPS (Basic) Growth
| -17.27% | -12.15% | +12.24% | -166.85% | |
Basic Shares Outstanding
| 169.88M | 169.88M | 154.17M | 162.12M | |
EPS (Diluted)
| -1.7527 | -1.9657 | -1.7251 | -4.6035 | |
EPS (Diluted) Growth
| -17.27% | -12.15% | +12.24% | -166.85% | |
Diluted Shares Outstanding
| 169.88M | 169.88M | 154.17M | 162.12M | |
EBITDA
| (220.10M) | (238.73M) | (163.15M) | (651.14M) | |
EBITDA Growth
| -28.80% | -8.47% | +31.66% | -299.10% | |
EBITDA Margin
| -85.36% | -74.45% | -30.68% | -93.91% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 61.30 | |
| Number of Ratings | 14 | Current Quarters Estimate | -0.182 | |
| FY Report Date | 06 / 2025 | Current Year's Estimate | -0.583 | |
| Last Quarter’s Earnings | -0.24 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -1.58 | Next Fiscal Year Estimate | 0.143 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 7 | 7 | 8 | 7 |
| Mean Estimate | -0.18 | -0.09 | -0.58 | 0.14 |
| High Estimates | -0.15 | -0.07 | -0.40 | 0.72 |
| Low Estimate | -0.23 | -0.15 | -0.82 | -0.41 |
| Coefficient of Variance | -17.09 | -33.43 | -23.55 | 296.29 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 6 | 5 | 8 |
| OVERWEIGHT | 1 | 1 | 0 |
| HOLD | 7 | 7 | 3 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Tempus Ai - TEM
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Tempus Ai - TEM
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Apr 4, 2025 | Ryan Fukushima Chief Operating Officer | 906,476 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.02 per share | 43,528,977.52 |
| Apr 4, 2025 | Ryan Fukushima Chief Operating Officer | 909,576 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $47.07 per share | 42,813,742.32 |
| Apr 4, 2025 | Ryan Fukushima Chief Operating Officer | 921,160 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $46.02 per share | 42,391,783.20 |
| Apr 4, 2025 | Scott Gottlieb Director | 35,397 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.13 per share | 1,703,657.61 |
| Apr 4, 2025 | Scott Gottlieb Director | 39,397 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $47.1 per share | 1,855,598.70 |
| Apr 4, 2025 | Scott Gottlieb Director | 55,670 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $46.07 per share | 2,564,716.90 |
| Apr 4, 2025 | Scott Gottlieb Director | 32,839 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.69 per share | 1,598,930.91 |
| Apr 4, 2025 | Ryan Fukushima Chief Operating Officer | 904,460 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.66 per share | 44,011,023.60 |
| Apr 4, 2025 | Jennifer A. Doudna Director | 25,740 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.12 per share | 1,238,608.80 |
| Mar 21, 2025 | Jennifer A. Doudna Director | 27,265 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $50.04 per share | 1,364,340.60 |
| Mar 21, 2025 | James Patrick Rogers Chief Financial Officer | 170,612 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $45.78 per share | 7,810,617.36 |
| Mar 21, 2025 | James Patrick Rogers Chief Financial Officer | 165,450 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $46.41 per share | 7,678,534.50 |
| Mar 21, 2025 | Jennifer A. Doudna Director | 30,407 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.9 per share | 1,486,902.30 |
| Mar 21, 2025 | James Patrick Rogers Chief Financial Officer | 164,750 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $47.4 per share | 7,809,150.00 |
| Mar 21, 2025 | Scott Gottlieb Director | 60,676 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $50.45 per share | 3,061,104.20 |
| Mar 21, 2025 | Jennifer A. Doudna Director | 26,365 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $50.63 per share | 1,334,859.95 |
| Mar 21, 2025 | Jennifer A. Doudna Director | 31,621 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.11 per share | 1,521,286.31 |
| Mar 21, 2025 | Wayne A. I. Frederick Director | 34,805 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $47.99 per share | 1,670,291.95 |
| Mar 21, 2025 | Wayne A. I. Frederick Director | 30,517 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $49.99 per share | 1,525,544.83 |
| Mar 21, 2025 | Wayne A. I. Frederick Director | 29,514 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $50.62 per share | 1,493,998.68 |
Tempus Ai in the News
Pelosi discloses sales of Nvidia and Apple shares, purchase of Alphabet and Amazon
Former House Speaker Nancy Pelosi, D-Calif., disclosed several new stock trades involving Big Tech names like Nvidia, Apple, Alphabet and Amazon that occurred in the last month.